In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: HCA Healthcare's current price lies below the PERT-weighted fair value, indicating potential undervaluation with a 39.8% implied upside and high confidence. Strong efficiency and leverage contrast with weak profitability and growth, reflecting operational stability amid financial stress. Monte Carlo analysis reveals significant volatility and a 38.9% downside risk, highlighting considerable investment uncertainty.